Approval · Notice of Compliance 2527 · 2001
PRIMAQUINE: Notice of Compliance 2527
Issued April 2, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2527
- Date
- April 2, 2001
- Company
- Sanofi-Synthelabo Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antimalarial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRIMAQUINE | 02017776 | Marketed |
Medicinal ingredients
- PRIMAQUINE PHOSPHATE 15 MG per TAB